Neuroprotection for treatment of glaucoma in adults (Q24240024)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Neuroprotection for treatment of glaucoma in adults (English)

0 references

author

Kristina Lindsley

series ordinal

3

0 references

author name string

Dayse F Sena

series ordinal

1

0 references

Kanchan Ramchand

series ordinal

2

0 references

language of work or name

English

0 references

publication date

2010

0 references

published in

0 references

issue

2

0 references

page(s)

CD006539

0 references

cites work

The number of people with glaucoma worldwide in 2010 and 2020

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Global data on visual impairment in the year 2002

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Medical interventions for primary open angle glaucoma and ocular hypertension

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

How to identify randomized controlled trials in MEDLINE: ten years on

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Neuroprotection: extrapolating from neurologic diseases to the eye.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Neuroprotection in glaucoma: drug-based approaches.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Current management of glaucoma and the need for complete therapy.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

History of neuroprotection and rationale as a therapy for glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Evolving paradigms in the medical treatment of glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Gene-environment interactions in human diseases

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Early Manifest Glaucoma Trial update 2004

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Evaluation of neuroprotective qualities of brimonidine during LASIK.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Some Current Ideas on the Pathogenesis and the Role of Neuroprotection in Glaucomatous Optic Neuropathy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Medical treatment of normal tension glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Assessment of the retinal nerve fiber layer in clinical trials of glaucoma neuroprotection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Neuroprotection: a new treatment modality for glaucoma?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study. Ireland Latanoprost Study Group

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Is neuroprotection a viable therapy for glaucoma?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

New definitions of glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Normal tension glaucoma--a practical approach

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Vertical cup/disc ratio in relation to optic disc size: its value in the assessment of the glaucoma suspect

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Neuronal death in glaucoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Changing definition of glaucoma.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Potential treatment modalities for glaucomatous neuropathy: neuroprotection and neuroregeneration

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for neuroprotection.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Natural history of normal-tension glaucoma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Retrobulbar Arterial Hemodynamic Effects of Betaxolol and Timolol in Normal-Tension Glaucoma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma

30 May 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

Short-term effects of bimatoprost in glaucoma patients from an outpatient clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

The effects of latanoprost and brimonidine on blood flow velocity of the retrobulbar vessels: a 3-month clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

A comparison of the fixed combination of latanoprost and timolol with its individual components

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

Distribution of optineurin sequence variations in an ethnically diverse population of low-tension glaucoma patients from the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

Nitric oxide synthase in the human glaucomatous optic nerve head.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

Accuracy of clinical estimates of intraocular pressure in Chinese eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006539.PUB2

Special considerations in low-tension glaucoma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Neuroprotection with carotenoids in glaucoma

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

New conceptual approaches for pharmacological neuroprotection in glaucomatous neuronal degeneration.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3478138

Effect of topical apraclonidine on the frequency of intraocular pressure elevations after combined extracapsular cataract extraction and trabeculectomy

29 November 2018

1 reference

12 December 2020

Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group

1 reference

12 December 2020

The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group

1 reference

12 December 2020

Dorzolamide, visual function and ocular hemodynamics in normal-tension glaucoma

1 reference

12 December 2020

Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma

1 reference

12 December 2020

1 reference

12 December 2020

The short-time effect of latanoprost on the intraocular pressure in normal pressure glaucoma

1 reference

12 December 2020

Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma

1 reference

12 December 2020

Does reduction of intraocular pressure (IOP) prevent visual field loss in glaucoma?

1 reference

12 December 2020

Epidemiology of angle-closure glaucoma

1 reference

12 December 2020

Rescula as an alternative therapy for beta-blockers with long-term drift effect in glaucoma patients

1 reference

12 December 2020

Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium

1 reference

12 December 2020

Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability

1 reference

12 December 2020

10.1002/14651858.CD006539.PUB2

Identifiers

DOI

1 reference

1 reference

1 reference

PubMed publication ID

20166085

1 reference